Viatris (VTRS) Other Non Operating Income (2019 - 2026)
Viatris (VTRS) posted Other Non Operating Income of $50.4 million for Q2 2026, up 206.11% on a QoQ basis from -$47.5 million in Q1 2026, and up 115.11% year-over-year from $23.4 million in Q2 2025.
Analysis
Viatris (VTRS) Other Non Operating Income (2019 - 2026) Analysis & Trends
Viatris has reported Other Non Operating Income for 8 years, with the latest figure at $50.4 million in Q2 2026.
- On a quarterly basis, Other Non Operating Income rose 115.11% year-over-year to $50.4 million in Q2 2026; TTM through Jun 2026 was -$94.9 million, a 77.36% increase from a year earlier, with the FY2025 full-year figure at -$530.6 million, down 536.97% from the prior year.
- Other Non Operating Income was $50.4 million for Q2 2026 at Viatris, up from -$47.5 million in the prior quarter.
- The five-year high for Other Non Operating Income was $1.8 billion in Q4 2022, with the low at -$333.5 million in Q2 2025.
- Average Other Non Operating Income over 5 years is $78.9 million, with a median of -$1.3 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income jumped 8198.17% in 2022, then plunged 5367.21% in 2025.
- Over 5 years, Other Non Operating Income stood at $1.8 billion in 2022, then slumped by 114.28% to -$259.6 million in 2023, then soared by 101.31% to $3.4 million in 2024, then plunged by 1002.94% to -$30.7 million in 2025, then soared by 264.17% to $50.4 million in 2026.
- The last three Other Non Operating Income figures came in at $50.4 million (Q2 2026), -$47.5 million (Q1 2026), and -$30.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.40 Mn |
| Mar 31, 2026 | -47.50 Mn |
| Dec 31, 2025 | -30.70 Mn |
| Sep 30, 2025 | -67.10 Mn |
| Jun 30, 2025 | -333.50 Mn |
| Mar 31, 2025 | -99.30 Mn |
| Dec 31, 2024 | 3.40 Mn |
| Sep 30, 2024 | 10.20 Mn |
| Jun 30, 2024 | -6.10 Mn |
| Mar 31, 2024 | 139.10 Mn |
| Dec 31, 2023 | -259.60 Mn |
| Sep 30, 2023 | 92.00 Mn |
| Jun 30, 2023 | 107.50 Mn |
| Mar 31, 2023 | 69.90 Mn |
| Dec 31, 2022 | 1.82 Bn |
| Sep 30, 2022 | 20.60 Mn |
| Jun 30, 2022 | -13.50 Mn |
| Mar 31, 2022 | -33.70 Mn |
| Dec 31, 2021 | 21.90 Mn |
| Sep 30, 2021 | -5.80 Mn |